Long term I.V. Ig treatment in systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 12, Issue 2, 1994, Pages 163-168

  Francioni, C ^a   Galeazzi, M ^a   Fioravanti, A ^a   Gelli, R ^a   Megale, F ^a   Marcolongo, R ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

immunoglobulins; long term treatment; systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOSTATIC AGENT; HYDROXYCHLOROQUINE; IG VENA; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLUSHING; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIGEN-ANTIBODY COMPLEX; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOGLOBULINS, INTRAVENOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METHYLPREDNISOLONE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 0028322128     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)